Cwm, LLC Pacira Bio Sciences, Inc. Transaction History

Cwm, LLC

$36.9 Billion
Q4 2025

A detailed history of Cwm, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 7,857 shares of PCRX stock, worth $186,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,857

Previous 8,041 2.29%

Holding current value

$186,839

Previous $207,000 1.93%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 26, 2026	SELL	$21.01 - $25.27 $3,865 - $4,649	-184 Reduced 2.29%	7,857 $203,000
Q3 2025 Oct 15, 2025	SELL	$21.09 - $27.22 $28,724 - $37,073	-1,362 Reduced 14.48%	8,041 $207,000
Q2 2025 Jul 25, 2025	BUY	$22.91 - $27.14 $2,061 - $2,442	90 Added 0.97%	9,403 $225,000
Q1 2025 May 01, 2025	BUY	$18.33 - $27.25 $293 - $436	16 Added 0.17%	9,313 $231,000
Q4 2024 Feb 04, 2025	BUY	$15.3 - $20.33 $42,534 - $56,517	2,780 Added 42.66%	9,297 $175,000

Q3 2024 Oct 08, 2024	BUY	$11.7 - $28.46 $66,877 - $162,677	5,716 Added 713.61%	6,517 $98,000
Q2 2024 Jul 09, 2024	SELL	$25.5 - $31.51 $306 - $378	-12 Reduced 1.48%	801 $23,000
Q1 2024 Apr 05, 2024	BUY	$27.7 - $35.48 $1,412 - $1,809	51 Added 6.69%	813 $24,000
Q4 2023 Feb 01, 2024	SELL	$26.32 - $34.31 $526 - $686	-20 Reduced 2.56%	762 $26,000
Q3 2023 Oct 11, 2023	SELL	$30.68 - $40.09 $20,616 - $26,940	-672 Reduced 46.22%	782 $24,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $47.5 $1,119 - $1,472	31 Added 2.18%	1,454 $58,000
Q1 2023 Apr 28, 2023	BUY	$35.53 - $43.38 $34,819 - $42,512	980 Added 221.22%	1,423 $58,000
Q4 2022 Feb 01, 2023	BUY	$38.19 - $57.45 $572 - $861	15 Added 3.5%	443 $17,000
Q3 2022 Oct 27, 2022	BUY	$51.24 - $58.89 $5,124 - $5,889	100 Added 30.49%	428 $23,000
Q2 2022 Jul 28, 2022	SELL	$51.49 - $81.64 $875 - $1,387	-17 Reduced 4.93%	328 $19,000
Q1 2022 Apr 21, 2022	BUY	$60.03 - $76.49 $1,800 - $2,294	30 Added 9.52%	345 $26,000
Q4 2021 Jan 31, 2022	SELL	$47.97 - $62.21 $1,678 - $2,177	-35 Reduced 10.0%	315 $19,000
Q2 2019 Jul 31, 2019	BUY	$36.57 - $47.97 $12,799 - $16,789	350 New	350 $15,000
Q1 2019 Apr 22, 2019	SELL	$36.47 - $42.17 $328 - $379	-9 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$41.31 - $52.16 $371 - $469	9 New	9 $0

Others Institutions Holding PCRX

# of Institutions

267

Shares Held

48.8M

Call Options Held

118K

Put Options Held

63.7K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account